Aurobindo Pharma develops, manufactures, and commercializes a wide range of generic pharmaceuticals, active pharmaceutical ingredients (API), and injectables globally in over 150 countries.

The company, headquartered in Hyderabad, was founded in 1986 by Mr. P.V. Ramprasad Reddy, Mr. K. Nityananda Reddy, and a small group of highly committed professionals with a vision to make medicines accessible and affordable to patients across the globe. The company commenced its operations in 1988-89 with a single-unit manufacturing of Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges (ISE) in 1995.

external link